AffiliationMédecins Sans Frontières, Geneva, Switzerland.
MetadataShow full item record
AbstractGlobal commitments aim to provide antiretroviral therapy (ART) to 15 million people living with HIV by 2015, and recent studies have demonstrated the potential for widespread ART to prevent HIV transmission. Increasingly, countries are adapting their national guidelines to start ART earlier, for both clinical and preventive benefits. To maximize the benefits of ART in resource-limited settings, six key principles need to guide ART choice: simplicity, tolerability and safety, durability, universal applicability, affordability and heat stability. Currently available drugs, combined with those in late-stage clinical development, hold great promise to simplify treatment in the short term. Over the longer-term, newer technologies, such as long-acting formulations and nanotechnology, could radically alter the treatment paradigm. This commentary reviews recommendations made in an expert consultation on treatment scale up in resource-limited settings.
- Maximizing the benefits of antiretroviral therapy for key affected populations.
- Authors: Grubb IR, Beckham SW, Kazatchkine M, Thomas RM, Albers ER, Cabral M, Lange J, Vella S, Kurian M, Beyrer C, IAS Treatment for Key Affected Populations Working Group.
- Issue date: 2014
- Scaling up antiretroviral therapy in resource-limited settings: adapting guidance to meet the challenges.
- Authors: Vitoria M, Vella S, Ford N
- Issue date: 2013 Jan
- How have guidelines on when to start antiretroviral therapy affected survival of people living with HIV infection?
- Authors: Rodger AJ, Sabin CA
- Issue date: 2016 Sep
- Antiretroviral treatment French guidelines 2013: economics influencing science.
- Authors: Raffi F, Reynes J
- Issue date: 2014 May
- Beyond first-line HIV treatment regimens: the current state of antiretroviral regimens, viral load monitoring, and resistance testing in resource-limited settings.
- Authors: Kumarasamy N, Krishnan S
- Issue date: 2013 Nov